First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Hormone-Resistant Breast Cancer|Non Small Cell Lung Cancer|Mesothelioma
Interventions: DRUG: AG-01 Compound
Sponsor: A&G Pharmaceutical Inc.
Collaborators: University of Maryland Greenebaum Cancer Center